Agios Reports Business Highlights and First Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Agios Pharma (AGIO) Tops Q1 EPS by 23c
May 4, 2023 7:46 AM EDTAgios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.47), $0.23 better than the analyst estimate of ($1.70). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $5.37 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More